| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sirtuin 3 | 21 | 2022 | 31 | 3.870 |
Why?
|
| Neuroblastoma | 8 | 2025 | 551 | 3.380 |
Why?
|
| Adipocytes | 15 | 2020 | 179 | 2.590 |
Why?
|
| Gene Expression Regulation, Neoplastic | 12 | 2025 | 2124 | 1.770 |
Why?
|
| RNA, Long Noncoding | 3 | 2023 | 249 | 1.700 |
Why?
|
| Trans-Activators | 8 | 2021 | 832 | 1.490 |
Why?
|
| Cell Line, Tumor | 23 | 2025 | 3796 | 1.420 |
Why?
|
| Disease Progression | 9 | 2025 | 2249 | 1.300 |
Why?
|
| Immunotherapy | 7 | 2025 | 752 | 1.250 |
Why?
|
| Stomach Neoplasms | 5 | 2025 | 565 | 1.240 |
Why?
|
| Imidazoles | 3 | 2025 | 219 | 1.210 |
Why?
|
| YY1 Transcription Factor | 2 | 2024 | 18 | 1.070 |
Why?
|
| ELAV-Like Protein 1 | 3 | 2025 | 11 | 1.050 |
Why?
|
| Cell Line | 15 | 2023 | 2858 | 1.040 |
Why?
|
| Mice | 58 | 2025 | 18910 | 0.990 |
Why?
|
| RNA-Binding Proteins | 5 | 2025 | 622 | 0.980 |
Why?
|
| Proto-Oncogene Proteins | 8 | 2021 | 624 | 0.970 |
Why?
|
| Forkhead Transcription Factors | 7 | 2017 | 390 | 0.960 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2024 | 26 | 0.900 |
Why?
|
| Nanoparticles | 6 | 2025 | 289 | 0.860 |
Why?
|
| Mice, Inbred C57BL | 16 | 2025 | 4826 | 0.850 |
Why?
|
| Tumor Microenvironment | 4 | 2025 | 698 | 0.850 |
Why?
|
| Cell Differentiation | 12 | 2020 | 2025 | 0.830 |
Why?
|
| Mitochondria | 12 | 2021 | 757 | 0.820 |
Why?
|
| Sirtuins | 5 | 2011 | 21 | 0.820 |
Why?
|
| RNA, Messenger | 9 | 2024 | 2880 | 0.790 |
Why?
|
| Animals | 67 | 2025 | 36122 | 0.790 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2024 | 218 | 0.780 |
Why?
|
| Lymph Nodes | 1 | 2024 | 397 | 0.770 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2020 | 299 | 0.770 |
Why?
|
| Gluconeogenesis | 2 | 2022 | 111 | 0.750 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2022 | 50 | 0.750 |
Why?
|
| Transcription Factors | 14 | 2023 | 2720 | 0.750 |
Why?
|
| Sirtuin 2 | 5 | 2017 | 11 | 0.750 |
Why?
|
| Up-Regulation | 6 | 2020 | 911 | 0.740 |
Why?
|
| Adipose Tissue, Brown | 7 | 2019 | 87 | 0.740 |
Why?
|
| Histones | 3 | 2023 | 572 | 0.680 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein U | 1 | 2020 | 8 | 0.660 |
Why?
|
| CCCTC-Binding Factor | 1 | 2020 | 24 | 0.660 |
Why?
|
| Glioblastoma | 1 | 2023 | 373 | 0.630 |
Why?
|
| Acetylation | 11 | 2023 | 196 | 0.620 |
Why?
|
| Promoter Regions, Genetic | 10 | 2024 | 1422 | 0.620 |
Why?
|
| Glycolysis | 1 | 2020 | 173 | 0.620 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 169 | 0.610 |
Why?
|
| DNA-Binding Proteins | 7 | 2023 | 2145 | 0.600 |
Why?
|
| GATA2 Transcription Factor | 8 | 2023 | 47 | 0.590 |
Why?
|
| Hepatocytes | 5 | 2022 | 246 | 0.590 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2020 | 150 | 0.590 |
Why?
|
| Oxidative Stress | 5 | 2022 | 868 | 0.580 |
Why?
|
| beta Catenin | 1 | 2020 | 231 | 0.570 |
Why?
|
| Transcriptional Activation | 5 | 2024 | 501 | 0.570 |
Why?
|
| AMP-Activated Protein Kinases | 4 | 2020 | 176 | 0.560 |
Why?
|
| Macrophages | 5 | 2025 | 698 | 0.530 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 407 | 0.530 |
Why?
|
| Protein Binding | 10 | 2024 | 1850 | 0.520 |
Why?
|
| Reactive Oxygen Species | 7 | 2021 | 526 | 0.510 |
Why?
|
| Sirtuin 1 | 4 | 2021 | 54 | 0.500 |
Why?
|
| Cell Proliferation | 7 | 2025 | 2565 | 0.470 |
Why?
|
| Insulin Resistance | 4 | 2021 | 700 | 0.470 |
Why?
|
| Caloric Restriction | 4 | 2010 | 97 | 0.460 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 740 | 0.460 |
Why?
|
| Humans | 58 | 2025 | 133529 | 0.450 |
Why?
|
| Adipose Tissue | 6 | 2021 | 510 | 0.450 |
Why?
|
| Malates | 2 | 2024 | 8 | 0.430 |
Why?
|
| Mitochondrial Proteins | 7 | 2022 | 256 | 0.430 |
Why?
|
| Aspartic Acid | 2 | 2024 | 85 | 0.410 |
Why?
|
| GATA3 Transcription Factor | 4 | 2007 | 44 | 0.410 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2011 | 277 | 0.410 |
Why?
|
| Signal Transduction | 14 | 2025 | 4918 | 0.400 |
Why?
|
| PPAR gamma | 3 | 2019 | 89 | 0.380 |
Why?
|
| Adipogenesis | 5 | 2020 | 82 | 0.380 |
Why?
|
| Interferon Regulatory Factors | 1 | 2012 | 43 | 0.370 |
Why?
|
| Multiple Myeloma | 3 | 2020 | 204 | 0.370 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2011 | 21 | 0.360 |
Why?
|
| Mice, Inbred BALB C | 5 | 2024 | 1085 | 0.360 |
Why?
|
| Adipose Tissue, White | 2 | 2011 | 93 | 0.360 |
Why?
|
| HEK293 Cells | 7 | 2020 | 826 | 0.360 |
Why?
|
| Muscle, Skeletal | 3 | 2018 | 1037 | 0.350 |
Why?
|
| Dendrimers | 3 | 2025 | 10 | 0.340 |
Why?
|
| Helicobacter pylori | 1 | 2020 | 1335 | 0.330 |
Why?
|
| Helicobacter Infections | 1 | 2020 | 1277 | 0.330 |
Why?
|
| Autophagy | 4 | 2022 | 431 | 0.330 |
Why?
|
| Proteins | 5 | 2010 | 1090 | 0.320 |
Why?
|
| Lipolysis | 3 | 2019 | 83 | 0.320 |
Why?
|
| Heterografts | 2 | 2020 | 201 | 0.310 |
Why?
|
| Body Composition | 3 | 2019 | 564 | 0.310 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 2 | 2008 | 15 | 0.300 |
Why?
|
| Histone Deacetylases | 2 | 2010 | 125 | 0.300 |
Why?
|
| Cytokines | 2 | 2012 | 1381 | 0.290 |
Why?
|
| Physical Conditioning, Animal | 1 | 2009 | 98 | 0.290 |
Why?
|
| Adiponectin | 2 | 2006 | 128 | 0.290 |
Why?
|
| Thermogenesis | 3 | 2019 | 52 | 0.280 |
Why?
|
| Neoplasms | 4 | 2025 | 2987 | 0.280 |
Why?
|
| Doxorubicin | 2 | 2022 | 302 | 0.270 |
Why?
|
| RNA, Small Interfering | 4 | 2022 | 719 | 0.270 |
Why?
|
| Lipid Metabolism | 5 | 2023 | 387 | 0.270 |
Why?
|
| Reperfusion Injury | 2 | 2021 | 114 | 0.270 |
Why?
|
| Aging | 3 | 2011 | 1270 | 0.260 |
Why?
|
| Mice, Obese | 2 | 2022 | 75 | 0.260 |
Why?
|
| Forkhead Box Protein O1 | 4 | 2017 | 99 | 0.260 |
Why?
|
| Polyethylene Glycols | 2 | 2025 | 253 | 0.260 |
Why?
|
| Phagocytosis | 2 | 2025 | 194 | 0.250 |
Why?
|
| Mammary Glands, Human | 1 | 2007 | 85 | 0.250 |
Why?
|
| 3T3 Cells | 5 | 2020 | 127 | 0.250 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 6 | 1998 | 148 | 0.240 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2025 | 2 | 0.240 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2025 | 10 | 0.240 |
Why?
|
| MicroRNAs | 2 | 2023 | 945 | 0.240 |
Why?
|
| Uncoupling Protein 1 | 3 | 2019 | 32 | 0.230 |
Why?
|
| Repressor Proteins | 2 | 2008 | 872 | 0.230 |
Why?
|
| Mice, Nude | 3 | 2025 | 779 | 0.230 |
Why?
|
| Cell Lineage | 1 | 2007 | 364 | 0.230 |
Why?
|
| RNA, Small Nucleolar | 1 | 2025 | 16 | 0.230 |
Why?
|
| Dendritic Cells | 2 | 2025 | 449 | 0.230 |
Why?
|
| Hyaluronan Receptors | 1 | 2025 | 68 | 0.230 |
Why?
|
| Particle Size | 1 | 2024 | 148 | 0.220 |
Why?
|
| Mice, Knockout | 12 | 2021 | 3978 | 0.220 |
Why?
|
| Models, Biological | 2 | 2020 | 1530 | 0.220 |
Why?
|
| Gene Knockdown Techniques | 3 | 2021 | 400 | 0.220 |
Why?
|
| RNA Interference | 3 | 2019 | 546 | 0.210 |
Why?
|
| Alternative Splicing | 2 | 2025 | 377 | 0.210 |
Why?
|
| Prodrugs | 1 | 2024 | 64 | 0.210 |
Why?
|
| RNA, Transfer | 1 | 2024 | 76 | 0.210 |
Why?
|
| Acetyl Coenzyme A | 1 | 2023 | 15 | 0.210 |
Why?
|
| Protein Isoforms | 4 | 2018 | 432 | 0.210 |
Why?
|
| Mammary Glands, Animal | 1 | 2007 | 479 | 0.210 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 4766 | 0.210 |
Why?
|
| RNA, Antisense | 1 | 2023 | 36 | 0.210 |
Why?
|
| Lysosomes | 1 | 2025 | 266 | 0.210 |
Why?
|
| Apoptosis | 4 | 2021 | 1938 | 0.200 |
Why?
|
| NF-kappa B | 1 | 2025 | 479 | 0.200 |
Why?
|
| Lipid Droplets | 2 | 2020 | 50 | 0.200 |
Why?
|
| Niacinamide | 2 | 2021 | 31 | 0.200 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2023 | 249 | 0.190 |
Why?
|
| HIV-1 | 1 | 2006 | 486 | 0.190 |
Why?
|
| Ribosomes | 1 | 2023 | 141 | 0.190 |
Why?
|
| Epithelial Cells | 1 | 2007 | 937 | 0.190 |
Why?
|
| Down-Regulation | 3 | 2021 | 712 | 0.190 |
Why?
|
| Obesity | 8 | 2021 | 2438 | 0.190 |
Why?
|
| Diet | 1 | 2009 | 1174 | 0.190 |
Why?
|
| Osteoblasts | 2 | 2020 | 164 | 0.190 |
Why?
|
| Oxygen Consumption | 3 | 2015 | 309 | 0.180 |
Why?
|
| Drosophila Proteins | 6 | 1998 | 771 | 0.180 |
Why?
|
| Proto-Oncogenes | 3 | 1998 | 36 | 0.180 |
Why?
|
| Berberine | 1 | 2021 | 10 | 0.180 |
Why?
|
| Nuclear Proteins | 3 | 2023 | 1340 | 0.180 |
Why?
|
| DNA Helicases | 1 | 2023 | 244 | 0.180 |
Why?
|
| Pyridinium Compounds | 1 | 2021 | 23 | 0.180 |
Why?
|
| Nanomedicine | 1 | 2021 | 26 | 0.180 |
Why?
|
| Liver Regeneration | 1 | 2021 | 41 | 0.180 |
Why?
|
| Mitochondria, Liver | 1 | 2021 | 36 | 0.180 |
Why?
|
| Carrier Proteins | 4 | 2005 | 1071 | 0.170 |
Why?
|
| Protein Stability | 2 | 2011 | 175 | 0.170 |
Why?
|
| Blotting, Western | 6 | 2015 | 1136 | 0.170 |
Why?
|
| Cardiolipins | 2 | 2018 | 19 | 0.170 |
Why?
|
| Liver | 2 | 2022 | 1845 | 0.170 |
Why?
|
| Ubiquitination | 2 | 2011 | 186 | 0.170 |
Why?
|
| Exosomes | 1 | 2021 | 57 | 0.170 |
Why?
|
| Tripartite Motif Proteins | 1 | 2020 | 20 | 0.170 |
Why?
|
| Cell Polarity | 1 | 2021 | 126 | 0.170 |
Why?
|
| Symporters | 2 | 1998 | 78 | 0.170 |
Why?
|
| Oncogene Proteins, Fusion | 3 | 1997 | 233 | 0.170 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2022 | 211 | 0.170 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2020 | 20 | 0.170 |
Why?
|
| Male | 22 | 2025 | 65657 | 0.170 |
Why?
|
| Gene Expression Regulation | 5 | 2011 | 2649 | 0.170 |
Why?
|
| Lipid Mobilization | 1 | 2020 | 3 | 0.160 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2020 | 7 | 0.160 |
Why?
|
| Dynamins | 1 | 2020 | 44 | 0.160 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2020 | 15 | 0.160 |
Why?
|
| Hexokinase | 1 | 2020 | 25 | 0.160 |
Why?
|
| Colorectal Neoplasms | 2 | 2025 | 647 | 0.160 |
Why?
|
| Mitochondria, Heart | 2 | 2022 | 53 | 0.160 |
Why?
|
| Protein Interaction Maps | 1 | 2020 | 91 | 0.160 |
Why?
|
| Antineoplastic Agents | 3 | 2025 | 1854 | 0.160 |
Why?
|
| Forkhead Box Protein O3 | 2 | 2011 | 31 | 0.160 |
Why?
|
| RNAi Therapeutics | 1 | 2019 | 18 | 0.160 |
Why?
|
| Female | 15 | 2025 | 71560 | 0.160 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 22 | 0.160 |
Why?
|
| Metronidazole | 1 | 2020 | 157 | 0.160 |
Why?
|
| NAD | 2 | 2009 | 50 | 0.160 |
Why?
|
| RNA Stability | 1 | 2020 | 87 | 0.160 |
Why?
|
| Cell Communication | 1 | 2020 | 190 | 0.150 |
Why?
|
| Glucose | 2 | 2022 | 907 | 0.150 |
Why?
|
| Neutrophils | 1 | 2021 | 368 | 0.150 |
Why?
|
| Amoxicillin | 1 | 2020 | 125 | 0.150 |
Why?
|
| Metaplasia | 1 | 2020 | 219 | 0.150 |
Why?
|
| Bone Diseases | 1 | 2019 | 45 | 0.150 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2020 | 120 | 0.150 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 229 | 0.150 |
Why?
|
| Lignans | 1 | 2018 | 6 | 0.150 |
Why?
|
| Cytoprotection | 1 | 2018 | 38 | 0.150 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-2 | 1 | 2018 | 16 | 0.140 |
Why?
|
| Biphenyl Compounds | 1 | 2018 | 63 | 0.140 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2018 | 52 | 0.140 |
Why?
|
| Fasting | 2 | 2009 | 309 | 0.140 |
Why?
|
| Cellular Reprogramming | 1 | 2019 | 130 | 0.140 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2017 | 20 | 0.140 |
Why?
|
| Bone Marrow | 1 | 2019 | 332 | 0.140 |
Why?
|
| Leucine Zippers | 1 | 1997 | 18 | 0.140 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 392 | 0.130 |
Why?
|
| Thyroid Neoplasms | 6 | 1998 | 258 | 0.130 |
Why?
|
| Cell Movement | 1 | 2021 | 907 | 0.130 |
Why?
|
| Muscle Proteins | 1 | 2020 | 418 | 0.130 |
Why?
|
| Membrane Proteins | 3 | 2005 | 1613 | 0.130 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2017 | 127 | 0.130 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2017 | 76 | 0.130 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2008 | 39 | 0.130 |
Why?
|
| Carcinoma, Papillary | 5 | 1998 | 96 | 0.130 |
Why?
|
| Amyloid beta-Peptides | 1 | 2018 | 245 | 0.130 |
Why?
|
| Glycoproteins | 2 | 2018 | 381 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2020 | 1584 | 0.120 |
Why?
|
| Rats | 7 | 2022 | 3848 | 0.120 |
Why?
|
| alpha-Synuclein | 1 | 2017 | 134 | 0.120 |
Why?
|
| Fatty Acids | 1 | 2018 | 367 | 0.120 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2022 | 831 | 0.120 |
Why?
|
| Lysine | 2 | 2017 | 207 | 0.120 |
Why?
|
| 3T3-L1 Cells | 2 | 2020 | 58 | 0.120 |
Why?
|
| Phosphorylation | 4 | 2017 | 1708 | 0.120 |
Why?
|
| Sex Characteristics | 3 | 2021 | 335 | 0.110 |
Why?
|
| Myocytes, Cardiac | 2 | 2022 | 644 | 0.110 |
Why?
|
| Intestinal Mucosa | 1 | 2020 | 817 | 0.110 |
Why?
|
| HIV Infections | 2 | 2006 | 2023 | 0.110 |
Why?
|
| Computational Biology | 1 | 2020 | 884 | 0.110 |
Why?
|
| Ureaplasma urealyticum | 1 | 2014 | 2 | 0.110 |
Why?
|
| Molecular Sequence Data | 8 | 2010 | 3958 | 0.110 |
Why?
|
| Oncogene Proteins | 1 | 1995 | 157 | 0.110 |
Why?
|
| Ureaplasma Infections | 1 | 2014 | 9 | 0.110 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2015 | 127 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2017 | 1321 | 0.110 |
Why?
|
| Mice, Transgenic | 6 | 2022 | 2520 | 0.110 |
Why?
|
| Transfection | 4 | 2011 | 1095 | 0.110 |
Why?
|
| Citrate (si)-Synthase | 2 | 2014 | 19 | 0.110 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 398 | 0.110 |
Why?
|
| Progesterone | 1 | 2016 | 635 | 0.110 |
Why?
|
| Kidney | 1 | 2021 | 1382 | 0.110 |
Why?
|
| Endometrium | 1 | 2016 | 291 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2015 | 548 | 0.100 |
Why?
|
| Hedgehog Proteins | 1 | 2015 | 268 | 0.100 |
Why?
|
| Homeostasis | 4 | 2022 | 747 | 0.100 |
Why?
|
| Glucagon-Like Peptide 2 | 1 | 2013 | 55 | 0.100 |
Why?
|
| Thyroid Gland | 5 | 1998 | 117 | 0.100 |
Why?
|
| Insulin | 2 | 2012 | 1230 | 0.100 |
Why?
|
| Caspase 3 | 1 | 2013 | 139 | 0.100 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2013 | 79 | 0.100 |
Why?
|
| Adenocarcinoma | 1 | 2020 | 1039 | 0.100 |
Why?
|
| Camptothecin | 1 | 2013 | 79 | 0.100 |
Why?
|
| Ion Channels | 3 | 2014 | 209 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 1912 | 0.100 |
Why?
|
| Enzyme Activation | 3 | 2020 | 640 | 0.100 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2013 | 111 | 0.090 |
Why?
|
| Deoxyglucose | 1 | 2012 | 42 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 997 | 0.090 |
Why?
|
| Receptors, Ghrelin | 1 | 2011 | 29 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2009 | 804 | 0.090 |
Why?
|
| RAW 264.7 Cells | 2 | 2024 | 47 | 0.090 |
Why?
|
| NADPH Oxidases | 1 | 2012 | 115 | 0.090 |
Why?
|
| Chaperonin 60 | 1 | 2011 | 31 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 348 | 0.090 |
Why?
|
| Genomic Instability | 1 | 2013 | 246 | 0.090 |
Why?
|
| Half-Life | 1 | 2011 | 162 | 0.090 |
Why?
|
| Gene Silencing | 1 | 2012 | 246 | 0.090 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 1697 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-jun | 2 | 2009 | 39 | 0.090 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2014 | 211 | 0.090 |
Why?
|
| Plasmids | 1 | 2012 | 528 | 0.090 |
Why?
|
| Subcellular Fractions | 1 | 2010 | 98 | 0.090 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2009 | 112 | 0.080 |
Why?
|
| Cell Cycle | 1 | 2013 | 620 | 0.080 |
Why?
|
| Gene Expression | 5 | 2000 | 1608 | 0.080 |
Why?
|
| Succinate Dehydrogenase | 1 | 2010 | 8 | 0.080 |
Why?
|
| Base Sequence | 5 | 2016 | 3153 | 0.080 |
Why?
|
| Prognosis | 1 | 2020 | 5052 | 0.080 |
Why?
|
| Animal Structures | 1 | 2009 | 14 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2017 | 740 | 0.080 |
Why?
|
| Models, Animal | 3 | 2019 | 480 | 0.080 |
Why?
|
| Ribosomal Proteins | 1 | 2009 | 76 | 0.080 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2009 | 46 | 0.080 |
Why?
|
| Protein Transport | 1 | 2010 | 388 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2009 | 60 | 0.080 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2009 | 21 | 0.080 |
Why?
|
| Longevity | 1 | 2010 | 159 | 0.080 |
Why?
|
| Isoproterenol | 1 | 2008 | 99 | 0.070 |
Why?
|
| Diet, High-Fat | 2 | 2021 | 243 | 0.070 |
Why?
|
| Cold Temperature | 1 | 2008 | 86 | 0.070 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2009 | 94 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-ret | 6 | 1998 | 36 | 0.070 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2001 | 396 | 0.070 |
Why?
|
| Superoxides | 2 | 2021 | 132 | 0.070 |
Why?
|
| HeLa Cells | 3 | 2017 | 839 | 0.070 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2009 | 323 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2017 | 3141 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2007 | 50 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 2009 | 221 | 0.070 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2007 | 77 | 0.070 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 677 | 0.070 |
Why?
|
| Oxidation-Reduction | 2 | 2021 | 463 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2020 | 614 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 1997 | 234 | 0.060 |
Why?
|
| Receptors, HIV | 1 | 2006 | 3 | 0.060 |
Why?
|
| Body Weight | 1 | 2010 | 1035 | 0.060 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2006 | 29 | 0.060 |
Why?
|
| Amino Acid Sequence | 4 | 2013 | 2784 | 0.060 |
Why?
|
| Methylation | 2 | 2019 | 232 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 1049 | 0.060 |
Why?
|
| Chromosome Mapping | 3 | 1998 | 1118 | 0.060 |
Why?
|
| Tissue Distribution | 2 | 2005 | 400 | 0.060 |
Why?
|
| Oncogenes | 2 | 1997 | 181 | 0.060 |
Why?
|
| Cell Membrane | 2 | 2018 | 482 | 0.060 |
Why?
|
| Interleukin-2 | 1 | 2006 | 246 | 0.060 |
Why?
|
| Calreticulin | 1 | 2025 | 23 | 0.060 |
Why?
|
| Silicon Dioxide | 1 | 2025 | 31 | 0.060 |
Why?
|
| CD47 Antigen | 1 | 2025 | 11 | 0.060 |
Why?
|
| Cell Respiration | 1 | 2005 | 25 | 0.060 |
Why?
|
| ADP Ribose Transferases | 1 | 2005 | 20 | 0.060 |
Why?
|
| Transcription, Genetic | 3 | 2016 | 1759 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2006 | 357 | 0.060 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2006 | 270 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2025 | 457 | 0.050 |
Why?
|
| Body Mass Index | 2 | 2017 | 1714 | 0.050 |
Why?
|
| Temperature | 1 | 2005 | 325 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2006 | 439 | 0.050 |
Why?
|
| DNA Primers | 3 | 2010 | 655 | 0.050 |
Why?
|
| Glycosylation | 1 | 2023 | 130 | 0.050 |
Why?
|
| Multiprotein Complexes | 1 | 2005 | 218 | 0.050 |
Why?
|
| Brain | 2 | 2018 | 3220 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2006 | 685 | 0.050 |
Why?
|
| Neurons | 1 | 2013 | 2050 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2006 | 511 | 0.050 |
Why?
|
| Lipoproteins, HDL | 1 | 2003 | 117 | 0.050 |
Why?
|
| Absorptiometry, Photon | 1 | 2003 | 206 | 0.050 |
Why?
|
| Glucose Tolerance Test | 1 | 2003 | 225 | 0.050 |
Why?
|
| E2F Transcription Factors | 1 | 2022 | 27 | 0.050 |
Why?
|
| Metallothionein | 1 | 2022 | 15 | 0.050 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2022 | 19 | 0.050 |
Why?
|
| Ubiquitin-Specific Proteases | 1 | 2022 | 22 | 0.050 |
Why?
|
| Ki-67 Antigen | 1 | 2022 | 119 | 0.050 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2022 | 66 | 0.050 |
Why?
|
| Protein Conformation | 2 | 2010 | 873 | 0.050 |
Why?
|
| Hormones, Ectopic | 1 | 2001 | 7 | 0.050 |
Why?
|
| Aged | 1 | 2020 | 21584 | 0.040 |
Why?
|
| Zinc | 1 | 2022 | 140 | 0.040 |
Why?
|
| RNA | 1 | 2005 | 606 | 0.040 |
Why?
|
| DNA | 2 | 2005 | 1675 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 1418 | 0.040 |
Why?
|
| Tyrosine | 2 | 2001 | 157 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 280 | 0.040 |
Why?
|
| Thiazolidinediones | 1 | 2001 | 86 | 0.040 |
Why?
|
| Antigens, Differentiation | 1 | 2020 | 67 | 0.040 |
Why?
|
| Zinc Fingers | 1 | 2000 | 125 | 0.040 |
Why?
|
| Receptors, Immunologic | 1 | 2020 | 127 | 0.040 |
Why?
|
| Thyrotropin | 2 | 1997 | 62 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2021 | 249 | 0.040 |
Why?
|
| Middle Aged | 1 | 2020 | 29081 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 3 | 2015 | 1101 | 0.040 |
Why?
|
| Autophagy-Related Protein-1 Homolog | 1 | 2019 | 11 | 0.040 |
Why?
|
| Mitochondrial Dynamics | 1 | 2020 | 55 | 0.040 |
Why?
|
| Luciferases | 2 | 2013 | 136 | 0.040 |
Why?
|
| Acetyl-CoA C-Acyltransferase | 1 | 2019 | 1 | 0.040 |
Why?
|
| Carbon-Carbon Double Bond Isomerases | 1 | 2019 | 1 | 0.040 |
Why?
|
| Adrenergic beta-3 Receptor Antagonists | 1 | 2019 | 1 | 0.040 |
Why?
|
| 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2019 | 10 | 0.040 |
Why?
|
| Enoyl-CoA Hydratase | 1 | 2019 | 7 | 0.040 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2019 | 11 | 0.040 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2019 | 29 | 0.040 |
Why?
|
| Racemases and Epimerases | 1 | 2019 | 12 | 0.040 |
Why?
|
| Sp1 Transcription Factor | 1 | 2019 | 45 | 0.040 |
Why?
|
| Child | 1 | 2020 | 25888 | 0.040 |
Why?
|
| Precision Medicine | 1 | 2022 | 361 | 0.040 |
Why?
|
| Bone Resorption | 1 | 2019 | 52 | 0.040 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2019 | 69 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 675 | 0.040 |
Why?
|
| Body Temperature Regulation | 1 | 2019 | 51 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2022 | 362 | 0.040 |
Why?
|
| Adult | 1 | 2020 | 31787 | 0.040 |
Why?
|
| Carnitine | 1 | 2019 | 72 | 0.040 |
Why?
|
| Adipokines | 1 | 2019 | 73 | 0.040 |
Why?
|
| Drug Carriers | 1 | 2019 | 119 | 0.040 |
Why?
|
| Renal Tubular Transport, Inborn Errors | 1 | 2018 | 4 | 0.040 |
Why?
|
| Oculocerebrorenal Syndrome | 1 | 2018 | 8 | 0.040 |
Why?
|
| Microtubules | 1 | 2019 | 132 | 0.040 |
Why?
|
| Estradiol | 1 | 2021 | 557 | 0.040 |
Why?
|
| Remission Induction | 1 | 2019 | 309 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 126 | 0.040 |
Why?
|
| Electron Transport | 1 | 2018 | 57 | 0.040 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2018 | 44 | 0.040 |
Why?
|
| Mitochondrial Membranes | 1 | 2018 | 32 | 0.040 |
Why?
|
| Osteogenesis | 1 | 2019 | 167 | 0.040 |
Why?
|
| RNA, Neoplasm | 2 | 1995 | 145 | 0.040 |
Why?
|
| Pheochromocytoma | 1 | 1998 | 39 | 0.040 |
Why?
|
| Thyroid Nuclear Factor 1 | 1 | 1997 | 14 | 0.040 |
Why?
|
| PAX8 Transcription Factor | 1 | 1997 | 16 | 0.040 |
Why?
|
| Receptors, Thyrotropin | 1 | 1997 | 12 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2019 | 356 | 0.030 |
Why?
|
| Proteinuria | 1 | 2018 | 111 | 0.030 |
Why?
|
| Skinfold Thickness | 1 | 2017 | 34 | 0.030 |
Why?
|
| Paired Box Transcription Factors | 1 | 1997 | 77 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2017 | 95 | 0.030 |
Why?
|
| Phospholipids | 1 | 2018 | 108 | 0.030 |
Why?
|
| Protein Kinases | 1 | 2019 | 340 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 98 | 0.030 |
Why?
|
| Thyroglobulin | 1 | 1997 | 7 | 0.030 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2017 | 10 | 0.030 |
Why?
|
| Myopia | 1 | 2018 | 133 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2017 | 206 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2017 | 318 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 2013 | 314 | 0.030 |
Why?
|
| Protein Aggregates | 1 | 2017 | 35 | 0.030 |
Why?
|
| COS Cells | 1 | 1997 | 286 | 0.030 |
Why?
|
| Neuroprotection | 1 | 2017 | 32 | 0.030 |
Why?
|
| Dopaminergic Neurons | 1 | 2017 | 53 | 0.030 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2018 | 158 | 0.030 |
Why?
|
| Mutation | 3 | 2017 | 6332 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2010 | 1146 | 0.030 |
Why?
|
| Body Height | 1 | 2017 | 228 | 0.030 |
Why?
|
| Lactation | 1 | 2017 | 199 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2016 | 299 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 1996 | 71 | 0.030 |
Why?
|
| Binding Sites | 3 | 2009 | 1379 | 0.030 |
Why?
|
| Birth Weight | 1 | 2017 | 355 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2017 | 240 | 0.030 |
Why?
|
| Stem Cells | 1 | 2000 | 748 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2018 | 481 | 0.030 |
Why?
|
| Testosterone | 1 | 2021 | 620 | 0.030 |
Why?
|
| Adipocytes, Brown | 1 | 2015 | 28 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2015 | 245 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 1995 | 186 | 0.030 |
Why?
|
| Proteomics | 1 | 2019 | 602 | 0.030 |
Why?
|
| Uncoupling Protein 2 | 1 | 2014 | 14 | 0.030 |
Why?
|
| Embryo Implantation | 1 | 2016 | 235 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 1996 | 268 | 0.030 |
Why?
|
| COUP Transcription Factor II | 1 | 2015 | 117 | 0.030 |
Why?
|
| Cilia | 1 | 2015 | 79 | 0.030 |
Why?
|
| Mothers | 1 | 2017 | 373 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2015 | 178 | 0.030 |
Why?
|
| Creatine Kinase, MM Form | 1 | 2014 | 5 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 1997 | 586 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2016 | 457 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1996 | 776 | 0.030 |
Why?
|
| Pregnancy | 2 | 2017 | 7598 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2015 | 268 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 2753 | 0.030 |
Why?
|
| Genetic Markers | 1 | 1996 | 622 | 0.030 |
Why?
|
| Physical Exertion | 1 | 2014 | 78 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 256 | 0.030 |
Why?
|
| Mitochondria, Muscle | 1 | 2014 | 39 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2017 | 806 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2014 | 126 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 1995 | 283 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 482 | 0.030 |
Why?
|
| Glucagon-Like Peptide-2 Receptor | 1 | 2013 | 11 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2017 | 485 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 500 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 844 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1996 | 540 | 0.030 |
Why?
|
| Inflammation | 1 | 2021 | 1567 | 0.030 |
Why?
|
| Cattle | 2 | 2009 | 586 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 1998 | 714 | 0.030 |
Why?
|
| Receptors, Glucagon | 1 | 2013 | 31 | 0.030 |
Why?
|
| M Phase Cell Cycle Checkpoints | 1 | 2013 | 6 | 0.030 |
Why?
|
| Muscle Strength | 1 | 2014 | 86 | 0.030 |
Why?
|
| Taurine | 1 | 1993 | 11 | 0.030 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2018 | 423 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2017 | 1173 | 0.020 |
Why?
|
| Introns | 2 | 2009 | 316 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2013 | 139 | 0.020 |
Why?
|
| Lentivirus | 1 | 2013 | 86 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2013 | 239 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2016 | 899 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 1014 | 0.020 |
Why?
|
| Sequence Alignment | 2 | 2009 | 631 | 0.020 |
Why?
|
| Mitosis | 1 | 2013 | 205 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2013 | 176 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 1993 | 186 | 0.020 |
Why?
|
| Ghrelin | 1 | 2011 | 55 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 1997 | 1827 | 0.020 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2010 | 19 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 1993 | 430 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 1586 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 511 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 1404 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 814 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2015 | 518 | 0.020 |
Why?
|
| Adiposity | 1 | 2011 | 207 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2009 | 69 | 0.020 |
Why?
|
| DNA Damage | 1 | 2013 | 517 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 643 | 0.020 |
Why?
|
| Minisatellite Repeats | 1 | 2009 | 45 | 0.020 |
Why?
|
| Chromatin | 1 | 2013 | 617 | 0.020 |
Why?
|
| Swine | 1 | 2013 | 1196 | 0.020 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 1 | 2009 | 10 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2009 | 112 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2009 | 35 | 0.020 |
Why?
|
| Eating | 1 | 2011 | 392 | 0.020 |
Why?
|
| Growth Disorders | 1 | 2010 | 222 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2010 | 297 | 0.020 |
Why?
|
| Granulocytes | 1 | 2009 | 71 | 0.020 |
Why?
|
| Heart Failure | 1 | 2022 | 2429 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 791 | 0.020 |
Why?
|
| Point Mutation | 1 | 2009 | 357 | 0.020 |
Why?
|
| Bone Density | 1 | 2010 | 374 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 385 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2011 | 814 | 0.020 |
Why?
|
| Peptides | 1 | 2009 | 863 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2010 | 828 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2005 | 269 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 354 | 0.010 |
Why?
|
| DNA, Neoplasm | 2 | 1996 | 302 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2017 | 8633 | 0.010 |
Why?
|
| Benzophenones | 1 | 2001 | 5 | 0.010 |
Why?
|
| Nerve Growth Factor | 1 | 2001 | 24 | 0.010 |
Why?
|
| Resistin | 1 | 2001 | 30 | 0.010 |
Why?
|
| Thiazoles | 1 | 2001 | 104 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 3364 | 0.010 |
Why?
|
| Iodides | 1 | 1998 | 15 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1998 | 190 | 0.010 |
Why?
|
| Multiple Endocrine Neoplasia Type 2a | 1 | 1998 | 3 | 0.010 |
Why?
|
| Receptor, EphB4 | 1 | 1998 | 3 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1998 | 28 | 0.010 |
Why?
|
| Receptors, Eph Family | 1 | 1998 | 22 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1998 | 171 | 0.010 |
Why?
|
| Hirschsprung Disease | 1 | 1998 | 38 | 0.010 |
Why?
|
| Neuropeptides | 1 | 1998 | 118 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2001 | 493 | 0.010 |
Why?
|
| Iodine | 1 | 1997 | 25 | 0.010 |
Why?
|
| Triiodothyronine | 1 | 1997 | 73 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 1997 | 89 | 0.010 |
Why?
|
| Thyroxine | 1 | 1997 | 74 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1997 | 203 | 0.010 |
Why?
|
| DNA Probes | 1 | 1996 | 125 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 1996 | 44 | 0.010 |
Why?
|
| Chromosome Inversion | 1 | 1996 | 77 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1998 | 677 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 1431 | 0.010 |
Why?
|
| Gene Dosage | 1 | 1996 | 456 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1994 | 470 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 1996 | 363 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1993 | 249 | 0.010 |
Why?
|
| Biological Transport | 1 | 1993 | 367 | 0.010 |
Why?
|
| Species Specificity | 1 | 1993 | 562 | 0.010 |
Why?
|
| Exons | 1 | 1994 | 824 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1993 | 911 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1993 | 958 | 0.010 |
Why?
|
| Cell Division | 1 | 1993 | 766 | 0.010 |
Why?
|
| Time Factors | 1 | 1997 | 6545 | 0.000 |
Why?
|